On Thursday, November 8 we had the honor of traveling to Montreal, Canada to speak at a Novartis Canada town hall meeting and share our story alongside CHOP's Dr. Stephan Grupp and the Lahti family.
On October 16, 2018, we had the honor of sharing our story and inspiring attendees at the Sysmex Symposium in Philadelphia.
On Friday, September 7 we traveled to Los Angeles to attend the sixth annual Stand Up To Cancer telecast. In a special moment during the show, Emily and fellow cancer survivor Nick were given the opportunity to thank the doctors and researchers who treated them.
On August 27, the European Commission announced that Novartis CAR-T cell therapy Kymriah has been approved to treat pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and relapsed/refractory diffuse large B-cell lymphoma (DLBCL) in Europe.
On August 10-11, we joined up with UMI Performance Inc. to host a bake sale and 50/50 drawing at the 7th Annual UMI Autocross & Cruise-In event in Clearfield, PA. In just two days, proceeds totaled to $2,500, later matched by Viking Performance to donate a total $5,000 to EWF.